Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer
- 1 July 2020
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 38 (7) , 639.e1-639.e9
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder CancerEuropean Urology, 2017
- Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancerCancer, 2016
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and OutcomesEuropean Urology, 2016
- Erratum: Gender differences in incidence and outcomes of urothelial and kidney cancerNature Reviews Urology, 2015
- Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerEuropean Urology, 2015
- Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysisCancer Epidemiology, 2013
- Impact of gender on bladder cancer incidence, staging, and prognosisWorld Journal of Urology, 2011
- The effect of age and gender on bladder cancer: a critical review of the literatureBJU International, 2010
- Sex and racial differences in bladder cancer presentation and mortality in the USCancer, 2008
- Factors Influencing Aggressive Therapy for Bladder Cancer: An Analysis of Data From the SEER ProgramJournal of Urology, 2003